Study to Evaluate Safety and Effectiveness of AdvaCoat Sinus Gel

PHASE4CompletedINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
Ethmoid SinusitisRhinosinusitis
Interventions
DEVICE

AdvaCoat sinus gel

A sterile,viscoelastic, bioresorbable gel composed of highly purified hyaluronan, a naturally occurring constituent of tissues in the body

DEVICE

Merogel Injectable

Bioresorbable hyaluronic acid product

Trial Locations (4)

35242

Alabama Nasal & Sinus Center, Birmingham

44125

Cleveland Nasal Sinus & Sleep, Cleveland

60611

Northwestern University Medical Center, Department of Otolaryngology, Chicago

94143

University of California, San Francisco, Dept of Otolaryngology, San Francisco

Sponsors
All Listed Sponsors
lead

Carbylan Therapeutics, Inc.

INDUSTRY